Dianthus Therapeutics, Inc.

DNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-K Mar 9, 2026 10-K
8-K Mar 9, 2026 8-K
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 17, 2026
4 Feb 4, 2026 4
4 Feb 4, 2026 4
4 Feb 4, 2026 4
4 Feb 4, 2026 4
4 Feb 4, 2026 4
EFFECT Jan 30, 2026
CORRESP Jan 29, 2026
UPLOAD Jan 29, 2026
S-3 Jan 28, 2026 S-3
8-K Jan 12, 2026 8-K
4 Dec 5, 2025 4
144 Dec 4, 2025
SCHEDULE 13D/A Nov 25, 2025
SCHEDULE 13D/A Nov 19, 2025
4 Nov 14, 2025 4
SCHEDULE 13G/A Nov 14, 2025
SCHEDULE 13G/A Nov 14, 2025
SCHEDULE 13G/A Nov 14, 2025
SCHEDULE 13G/A Nov 14, 2025
SCHEDULE 13G/A Nov 14, 2025
144 Nov 13, 2025
← Newer Page 4 of 27 · 658 filings Older →